(Q37776432)

23 August 2017

0 references

1 reference

title

p53 status and its prognostic role in extrahepatic bile duct cancer: a meta-analysis of published studies (English)

1 reference

23 August 2017

p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies (English)

1 reference

https://api.crossref.org/works/10.1007/S10620-010-1352-9

12 June 2024

1 reference

1 reference

intrahepatic bile duct

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20668938

12 June 2024

bile duct neoplasm

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20668938

12 June 2024

author name string

Juan Wang

1

1 reference

23 August 2017

Xuefeng Wang

2

1 reference

23 August 2017

Shuyang Xie

3

1 reference

23 August 2017

Zhonghai Yan

4

1 reference

23 August 2017

Zunling Li

5

1 reference

23 August 2017

Youjie Li

6

1 reference

23 August 2017

Lei Wang

7

1 reference

23 August 2017

Fei Jiao

8

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20668938

12 June 2024

publication date

29 July 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s10620-010-1352-9.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S10620-010-1352-9

http://link.springer.com/article/10.1007/s10620-010-1352-9/fulltext.html

12 June 2024

1 reference

https://api.crossref.org/works/10.1007/S10620-010-1352-9

http://link.springer.com/content/pdf/10.1007/s10620-010-1352-9

12 June 2024

1 reference

https://api.crossref.org/works/10.1007/S10620-010-1352-9

Digestive Diseases and Sciences

12 June 2024

published in

1 reference

23 August 2017

volume

56

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

655-662

1 reference

Diagnosis and management of cholangiocarcinoma.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Prognostic molecular markers in cholangiocarcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Circulating markers of biliary malignancy: opportunities in proteomics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Genetic prognostic and predictive markers in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p53 expression as a prognostic determinant in resected distal bile duct carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p53 protein expression in extrahepatic bile duct cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Prognostic molecular markers in hepatocellular carcinoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

The p53 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p53 in colorectal cancer: clinicopathological correlation and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p53 alterations in human cancer: more questions than answers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p53 Mutations in human cholangiocarcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

The p53 family in differentiation and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

The role of p53 protein family in gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p63 and p73 in human cancer: defining the network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

TP53 Mutations and mdm2 Protein Overexpression in Cholangiocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1352-9

Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts

21 January 2018

1 reference

12 December 2020

Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases

1 reference

12 December 2020

Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions

1 reference

12 December 2020

Selective reporting biases in cancer prognostic factor studies

1 reference

12 December 2020

Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct

1 reference

12 December 2020

Altered p21(WAF1/CIP1) expression is associated with poor prognosis in extrahepatic bile duct carcinoma

1 reference

12 December 2020

Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.

1 reference

12 December 2020

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

1 reference

12 December 2020

Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater

1 reference

12 December 2020

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

12 December 2020

Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts

1 reference

12 December 2020

Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study

1 reference

12 December 2020

Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases

1 reference

12 December 2020

P53 abnormalities and outcomes in colorectal cancer: a systematic review.

1 reference

12 December 2020

Journal of the National Cancer Institute

23

22

719

N Mantel

1959

1 reference

https://api.crossref.org/works/10.1007/S10620-010-1352-9

12 June 2024

Identifiers

1 reference

23 August 2017

1 reference